PHARVARIS NV(NASDAQ:PHVS) stock Fundamental Analysis

Fundamental Rating

PHVS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 195 industry peers in the Pharmaceuticals industry. While PHVS seems to be doing ok healthwise, there are quite some concerns on its profitability. PHVS does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year PHVS has reported negative net income.

PHVS had a negative operating cash flow in the past year.

PHVS had negative earnings in each of the past 5 years.

PHVS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

PHVS has a Return On Assets (-42.22%) which is comparable to the rest of the industry.

PHVS's Return On Equity of -44.55% is in line compared to the rest of the industry. PHVS outperforms 59.14% of its industry peers.

		Industry Rank	Sector Rank
ROA	-42.22%
ROE	-44.55%
ROIC	N/A

ROA(3y)-30.32%

ROA(5y)-31.13%

ROE(3y)-32.75%

ROE(5y)-33.66%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PHVS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for PHVS has been increased compared to 1 year ago.

The number of shares outstanding for PHVS has been increased compared to 5 years ago.

PHVS has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 32.52 indicates that PHVS is not in any danger for bankruptcy at the moment.

PHVS's Altman-Z score of 32.52 is amongst the best of the industry. PHVS outperforms 95.16% of its industry peers.

A Debt/Equity ratio of 0.00 indicates that PHVS is not too dependend on debt financing.

With a decent Debt to Equity ratio value of 0.00, PHVS is doing good in the industry, outperforming 60.22% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	32.52

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 19.08 indicates that PHVS has no problem at all paying its short term obligations.

The Current ratio of PHVS (19.08) is better than 91.94% of its industry peers.

A Quick Ratio of 19.08 indicates that PHVS has no problem at all paying its short term obligations.

PHVS has a Quick ratio of 19.08. This is amongst the best in the industry. PHVS outperforms 91.94% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	19.08
Quick Ratio	19.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PHVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.75%, which is quite good.

EPS 1Y (TTM)14.75%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-32.76%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 13.51% on average over the next years. This is quite good.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-1.24%

EPS Next 2Y-7.92%

EPS Next 3Y-4.15%

EPS Next 5Y13.51%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

PHVS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year PHVS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PHVS's earnings are expected to decrease with -4.15% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-7.92%

EPS Next 3Y-4.15%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

PHVS does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PHARVARIS NV

NASDAQ:PHVS (2/10/2025, 8:17:48 PM)

Premarket: 17.41 -0.45 (-2.49%)

17.855

-0.43 (-2.38%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)11-13 2024-11-13/amc

Earnings (Next)N/A N/A

Inst Owners57.34%

Inst Owner Change-83.47%

Ins Owners9.49%

Ins Owner ChangeN/A

Market Cap964.35M

Analysts84.29

Price Target34.55 (93.5%)

Short Float %0.48%

Short Ratio2.12

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-10.59%

Min EPS beat(2)-23.64%

Max EPS beat(2)2.46%

EPS beat(4)2

Avg EPS beat(4)-12.84%

Min EPS beat(4)-39.68%

Max EPS beat(4)9.5%

EPS beat(8)5

Avg EPS beat(8)-13.17%

EPS beat(12)9

Avg EPS beat(12)6.76%

EPS beat(16)10

Avg EPS beat(16)-13.6%

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-0.73%

PT rev (3m)-2.17%

EPS NQ rev (1m)-0.62%

EPS NQ rev (3m)-19.78%

EPS NY rev (1m)0%

EPS NY rev (3m)-8.54%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	3.15
P/tB	3.15
EV/EBITDA	N/A

EPS(TTM)-2.68

EYN/A

EPS(NY)-3.17

Fwd EYN/A

FCF(TTM)-2.09

FCFYN/A

OCF(TTM)-2.08

OCFYN/A

SpS0

BVpS5.67

TBVpS5.67

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-42.22%
ROE	-44.55%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-30.32%

ROA(5y)-31.13%

ROE(3y)-32.75%

ROE(5y)-33.66%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	165.79%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	19.08
Quick Ratio	19.08
Altman-Z	32.52

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)92.48%

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)14.75%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-32.76%

EPS Next Y-1.24%

EPS Next 2Y-7.92%

EPS Next 3Y-4.15%

EPS Next 5Y13.51%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-36.94%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-42.03%

EBIT Next 3Y-15.21%

EBIT Next 5YN/A

FCF growth 1Y-84.1%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-83.94%

OCF growth 3YN/A

OCF growth 5YN/A

PHARVARIS NV (PHVS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens